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Abstract : Cowden syndrome (CS) is an autosomal dominant inherited disorder characterized by macrocephaly 
and multiple hamartomas. The responsible gene is PTEN (phosphate and tensin homolog detected on chromo-
some 10), which negatively regulates cell proliferation and survival. We herein present a 46-year-old woman with 
the typical clinical features of CS. A DNA sequencing analysis of the coding regions and flanking introns of the 
PTEN gene revealed a novel heterozygous mutation (c.403A > G, p.Ile135Val) in exon 5 that had not been previ-
ously reported in CS. J. Med. Invest. 67 : 200-201, February, 2020
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INTRODUCTION
 
In 1963, Lloyd and Dennis reported Cowden syndrome (CS), 
also called Cowden disease, as a possible inherited symptom 
complex, including an adenoid face, trichilemmomas on the face, 
papillomatosis of the oral mucosa, and multiple thyroid adeno-
mas (1). Diagnostic criteria for CS were initially established in 
1996 and then revised in 2013 based on clinical experience and a 
large number of case reports (2). Besides multiple hamartomas, 
CS is recognized as a cancer-prone syndrome. A linkage analysis 
showed that a single locus within chromosome 10q22-23 was re-
sponsible for CS (3).  In 1997, with a focus on somatic mutations 
in cancer cell lines, Li et al. isolated the PTEN gene as a candidate 
tumor suppressor gene by mapping homozygous deletions within 
10q23 (4). After the identification of the PTEN gene, PTEN was 
proposed as the susceptibility gene for CS (5).  Many PTEN mu-
tations have since been detected in CS among unrelated patients 
or families (6). The sites of heterozygous mutations are distribut-
ed along whole PTEN exons, except for exon 9 (6). The detection 
of a germline mutation in a patient currently provides molecular 
confirmation for the diagnosis of CS.
CASE REPORT
A 46-year-old Chinese woman presented at our hospital with 
an increasing number of acral keratoses. The woman had moved 
from Xi’an to Tokyo at the age of 43 years and underwent a 
medical examination at another hospital in Tokyo that revealed 
multiple adenomas in the thyroid gland, cysts in both breasts, 
five benign gastrointestinal polyps, and an endometrial adeno-
ma. At the age of 45 years, asymptomatic verruciform papules 
appeared on the upper lips. Two months later, she noted smooth 
skin-colored papules on her palms and soles. When she present-
ed to our hospital, ten trichilemmoma-like papules were present 
on her face and multiple oral papillomas on the gingivae (Fig. 1). 
There were also several small keratotic papules on palmoplantar 
surfaces (Fig. 2). The histopathological findings of acral skin 
were hyperkeratosis, hypergranulosis, and acanthosis in the 
epidermis without inflammation and/or vasodilatation in the 
upper dermis. There were no signs of viral infection. Her head 
circumference was 61.5 cm, which was larger than the 97th per-
centile. No malignant tumors were detected in any organs. The 
PTEN Cleveland Clinic adult score (7) was 48, corresponding to 
a mutation probability of greater than 99%. Informed consent 
was obtained from the patient to analyze genomic DNA. A di-
rect DNA sequencing analysis showed a haplotype c.403A > G 
(adenine to guanine) mutation in exon 5 of the PTEN gene (Fig. 
3). The mutation resulted in a p.I135V (isoleucine to valine) 
substitution. Her family history was unclear because her father 
had already passed away. Based on the findings of a gene anal-
ysis performed in China, her clinically unaffected mother and 
half-sister from a different father did not carry the mutation. 
Since her diagnosis, the patient has undergone annual medical 
check-ups because the altered PTEN protein increases the risk 
of developing malignancy.
The Journal of Medical Investigation    Vol. 67  2020
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　
Received for publication May 21, 2019 ; accepted September 9, 2019.
Address correspondence and reprint requests to Yuriko Kawase, De-
partment of Dermatology, Toshiba Central Hospital, 6-3-22 Higashiooi 
Shinagawa-ku, Tokyo, 140-8522, Japan and Fax : +81-3-3764-3415.
Yoshiaki Kubo, Department of Dermatology, Tokushima University 
Graduate School of Medical Science, Kuramoto-cho, Tokushima, 770-
8503, Japan and Fax : +81-886-32-0434
Fig 1.　Cobble-like lesion on the gingiva
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DISCUSSION
CS is one of the PTEN hamartoma tumor syndromes (PHTS) 
and is characterized by hamartomas in several organs (8). 
Characteristic features of CS are macrocephaly, facial trichilem-
momas, acral keratosis, papillomatous papules, and thyroidal 
adenomas. Nodules and/or cysts in the thyroid gland may appear 
as the initial manifestation and are generally found one to two 
years prior to skin lesions. Papules on the skin and oral papillo-
mas typically appear in the second to third decade of life. The 
present middle-aged case had fewer hamartomas in each organ 
than age-matched typical CS cases diagnosed in their twenties 
due to the late onset of the disease.
The patient had an I135V mutation in exon 5 of the PTEN gene. 
This mutation had not been previously reported in CS ; however, 
a case of Bannayan-Riley-Ruvalcaba-syndrome, another phe-
notype of PHTS, had the same mutation (9). The mechanisms 
by which an identical mutation produces distinct phenotypic 
features have not yet been elucidated. A mutation in the PTEN 
gene is observed in 81% of CS cases, and 43% of CS patients 
harbor each mutation in exon 5 (10). Exon 5 encodes a core motif 
of phosphatidylinositol 3’-phosphatase, a key enzyme that neg-
atively regulates the PI-3 kinase pathway. Four missense mu-
tations (G129E, R130Q, R130L, and C136Y) and two nonsense 
mutations (R130X and L139X) have been identified near codon 
135 in CS individuals (6). The findings of an in silico analysis 
using PolyPhen-2 software (prediction of functional effects of 
human nsSNPs) suggested that this I135V mutation was dam-
aging with a score of 0.993 (11). Another analysis with fathmm 
software (Functional Analysis through Hidden Markov Models) 
indicated that the missense mutation damaged the function 
of the PTEN protein (12). The I135V mutation may cause the 
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Fig 2.　Keratotic papules on the right palm (arrows)
Fig 3.　A direct sequencing analysis of genomic DNA revealed an A 
to G transition at nucleotide position 403 in exon 5 of the PTEN gene.
